| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Articles |
From the Department of Physical Therapy (R.A., S.P.), Virginia Commonwealth University, Richmond, Va; Cardiology Division (J.M., J.A.), Veterans Administration Palo Alto Health Care System, Palo Alto, Calif; Cardiology Section (P.B., B.M., D.K.), Wake Forest University School of Medicine, Winston-Salem, NC; Department of Internal Medicine (R.A., M.A.P.), Virginia Commonwealth University, Richmond, Va; LeBauer Cardiovascular Research Foundation (D.B., P.C.), Greensboro, NC; Cardiovascular Division (D.F., E.W.), Brigham and Womens Hospital, Boston, Mass; and Cardiology Division (M.G.), Cardiopulmonary Laboratory, San Paolo Hospital, University of Milano, Milano, Italy.
Correspondence to Ross Arena, PhD, PT, Department of Physical Therapy, Box 980224, Virginia Commonwealth University, Health Sciences Campus, Richmond, VA 23298-0224. E-mail raarena{at}vcu.edu
Received November 6, 2008; accepted December 22, 2008.
Background— Peak oxygen consumption (VO2) is routinely assessed in patients with heart failure undergoing cardiopulmonary exercise testing. The purpose of the present investigation was to determine the prognostic ability of several established peak VO2 prediction equations in a large heart failure cohort.
Methods and Results— One thousand one hundred sixty-five subjects (70% males; age, 57.0±13.8 years; ischemic etiology, 43%) diagnosed with heart failure underwent cardiopulmonary exercise testing. Percent-predicted peak VO2 was calculated according to normative values proposed by Wasserman and Hansen (equation), Jones et al (equation), the Cooper Clinic (below low fitness threshold), a Veterans Administration male referral data set (4 equations), and the St James Take Heart Project for women (equation). The prognostic significance of percent-predicted VO2 values derived from the 2 latter, sex-specific equations were assessed collectively. There were 179 major cardiac events (117 deaths, 44 heart transplantations, and 18 left ventricular assist device implantations) during the 2-year tracking period (annual event rate, 10%). Measured peak VO2 and all percent-predicted peak VO2 calculations were significant univariate predictors of adverse events (
2
31.9, P<0.001) and added prognostic value to ventilatory efficiency (VE/VCO2 slope), the strongest cardiopulmonary exercise testing predictor of adverse events (
2=150.7, P<0.001), in a multivariate regression. The Wasserman/Hansen prediction equation provided optimal prognostic information.
Conclusions— Actual peak VO2 and the percent-predicted models included in this analysis all were significant predictors of adverse events. It seems that the percent-predicted peak VO2 value derived from the Wasserman/Hansen equations may outperform other expressions of this cardiopulmonary exercise testing variable.
Key Words: exercise heart failure prognosis ventilation
Related Article
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |